Pediatric Pneumococcal Eye Infection and Changes in Antibiotic Susceptibility: A Retrospective Study

Ui Yoon Choi1, Soo-Han Choi2, Doo Ri Kim3

  • 1Department of Pediatrics, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

PubMed

Insights

Pediatric pneumococcus isolates show increased penicillin non-susceptibility over time. Antimicrobial susceptibility to cefotaxime and levofloxacin remained stable in recent years.

Area of Science:

  • Ophthalmology
  • Microbiology
  • Pediatrics

Background:

  • * *Streptococcus pneumoniae* (pneumococcus) is a common cause of pediatric eye infections.
  • * Understanding antimicrobial susceptibility patterns is crucial for effective treatment.

Purpose of the Study:

  • * To analyze the antimicrobial susceptibility of pneumococcus from pediatric eye discharge.
  • * To compare susceptibility between age groups and two time periods (1994-2013 vs. 2014-2024).

Main Methods:

  • * Retrospective analysis of 65 pediatric patients with pneumococcus isolated from eye discharge.
  • * Stratification by age (<2 years vs. ≥2 years) and isolation period.
  • * Evaluation of susceptibility to penicillin, cefotaxime, and levofloxacin.

Main Results:

  • * No significant differences in antimicrobial susceptibility were observed between age groups.
  • * Susceptibility to cefotaxime and levofloxacin remained relatively stable between the two periods.
  • * A significant increase in non-susceptibility to penicillin was noted in the later period (16.7% vs. 48.5%, P=0.035).

Conclusions:

  • * Pediatric pneumococcus isolates demonstrate a concerning rise in penicillin non-susceptibility.
  • * Cefotaxime and levofloxacin maintain good susceptibility rates.
  • * This trend necessitates ongoing surveillance and potential adjustments in empirical treatment guidelines for pediatric conjunctivitis.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
595
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
306
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K